MTI Micro did get close to commercializing its Mobion fuel cell, which is powered by methanol. It was originally designed to charge and power cellphones and other personal electronic devices. But the device never had the success of Plug Power Inc (NASDAQ:PLUG), a local fuel cell company that has focused on the forklift truck market….
Bristol-Myers Squibb Co (NYSE:BMY)’s ipilimumab, or Yervoy as it’s commercially known, was dubbed the skin cancer ‘wonder’ drug by the media when it was licensed for use in the UK in 2011. Bristol-Myers Squibb Co (NYSE:BMY) dropped -0.33 percent to $54.00 Friday on volume of 8.05million shares. The intra-day range of the stock was $53.88…
CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last…
Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume…
Jive Software (NASDAQ:JIVE) was initiated with a Buy at B. Riley setting their target price at $17. Jive Software, Inc. (NASDAQ:JIVE) provides a social business software platform. The Company is focused on unlocking the power of the enterprise social graph, which is the extended social network of an enterprise, encompassing relationships among its employees, customers…
Pzifer(NYSE:PFE)’s stock was halted in afternoon trade following the announcement that the United States District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue patent (U.S. Patent No. RE44,048), covering methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex®. Pfizer (PFE) disagrees with the ruling and will…
